RECENT FUNDING
  1. Recent Funding
  2. Companies
  3. Addition Therapeutics

Addition Therapeutics

Addition Therapeutics develops genetic medicines using its proprietary PRINT technology.

Latest funding

$100M Series A ·

Led by Abingworth · Source: Pulse 2.0

Funding history ↓
Website: additiontx.com.
LinkedIn: linkedin.com.
Category: Health and bio.
Sectors: Biotechnology, Health Care, Life Science, Pharmaceutical.
Stage: Series A.
Based in: South San Francisco, United States.
Founded: 2021.
Last round: Dec 17, 2025 · 334 days ago.
Headcount: 11–50 employees.
On Recent Funding since: Oct 1, 2026.

Signals

Website registeredMay 25, 2021 (5 years old)
About Addition Therapeutics

This technology combines RNA therapeutics and gene therapies to deliver functional cures for patients with severe lifelong diseases. The company focuses on rare patient populations and aims to address larger related patient populations.

Funding rounds

DateRoundAmountLeadSource
Series A$100MAAbingworthPulse 2.0

Timeline

  1. Website created

Founders and team

Investors

Companies like Addition Therapeutics

Other companies backed by Abingworth

Abingworth portfolio →

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/addition-therapeutics (get a free API key).

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy